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Cardiac pacing devices and implantable cardioverter deﬁbrillator (ICD) are becoming the
mainstay of therapy in cardiology and infective endocarditis (IE) and pocket infection;
however, these devices require careful monitoring. Here, we describe a case of a 68-year-
old female with an ICD presenting with a previously unknown etiological agent of IE,
Corynebacterium mucifaciens.
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journal homepage: www.elsevier.com/locate/ihjFig. 1 – Transverse cut view of abdominal computed
tomography showing abscess at spleen.Currently, more than 3 million cardiac pacing systems and
180,000 implantable cardioverter deﬁbrillators (ICDs) have
been implanted worldwide.1 Despite the obvious beneﬁt of
these implantable devices, any complications that occur are
serious and life threatening to the patient especially if
misdiagnosed. One of the most important complications of
these implantable devices is infection, which may be
associated with the pocket and the leads.
A 68-year-old female was referred to the cardiology ward of
our hospital for removal of infected ICD leads. She had
previously been diagnosed with dilated cardiomyopathy and
an ICD was implanted for primary prevention 1 year ago. She
began to suffer from mild dyspnea and fatigue, and this was
followed by a weight loss of 14 kg since July 2014. The ﬁrst two
sets of blood cultures failed to detect any speciﬁc microorgan-
isms perhaps due to an inappropriate use of amoxicillin
clavulanate. However, a TEE in another hospital revealed a
small mobile vegetation on the atrial side of the ICD lead. A
hypodense lesion (abscess) in the spleen (33 mm  25 mm)
was also detected during follow-up with computerized
tomography (Fig. 1). Another TEE in our facility showed a
mobile vegetation with dimensions of 1.0 cm  0.6 cm over the
ICD lead on the atrial side and another vegetation with
dimensions of 1.6 cm  2.5 cm at the ostium of the superior
vena cava (Figs. 2 and 3). All blood samples drawn 11 days after
the previous set of samples were positive for and grew
Corynebacterium mucifaciens. This is the ﬁrst report of C.
mucifaciens as an etiological agent of endocarditis. Medicaltherapy was shifted from an IV combination of gentamycin
and sulbactam – ampicillin – to teicoplanin IV. Given the large
dimensions of the vegetations, a thoracotomy was performed
to remove the infected ICD and a splenectomy was performed
in addition to remove the abscess.
Cardiac-device-related infective endocarditis (IE) can be
divided into two groups based on the time of onset as early or
late IE, where 'early' indicates infection. It is called ‘‘early’’
cardiac-device-related IE when device-related IE occurs within
the ﬁrst 12 months of implantation and 'late' for infections
that occur after 1 year. Staphylococci, especially the coagulase-
negative species, Gram-negative bacilli, and diphtheroids are
Fig. 3 – Modified short-axis view of TEE showing a
vegetation of 1.0 cm T 0.6 cm in size over the ICD lead at
the atrial side.
Fig. 2 – Bicaval view of TEE showing a vegetation of
1.6 cm T 2.5 cm in size at the ostium of the superior vena
cava.
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while streptococci, enterococci, and Staphylococcus aureus
cause late device-related IE.2
While the preferred method of medically managing small
vegetations (≤1 cm in diameter) involves percutaneous re-
moval of the lead and generator, an explantation and change
of the device system via thoracotomy may be necessary when
the vegetation is bigger than 1 cm in diameter or when repair
of cardiac valves or other structures is indicated.
Corynebacterium spp. are part of the normal ﬂora and are
accepted skin contaminants. However, Corynebacterium spp.
are now thought to cause 9% of all early and 4% of all late
prosthetic valve endocarditis, but only 0.2–0.4% of all cases ofnative valve endocarditis.3 While reports of other species of
Corynebacterium being associated with endocarditis have been
published previously,4 this is the ﬁrst report of C. mucifaciens,
an etiological agent of IE.
C. mucifaciens is one of the newly described members of the
genus Corynebacterium, grows on blood agar, and forms slightly
yellow, circular, convex, mucoid colonies. It can produce acid
from glycerol, glucose, fructose, and mannose and demon-
strates catalase activity. It does not reduce nitrate or hydrolyze
esculin and urea,5 and while it can be identiﬁed using standard
biochemical tests, differentiation from closely related species
is done using molecular biology techniques.
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